Follow

Exercise of share options and Total Voting Rights

16 October 2020 - 13:44
RNS Number : 3668C
Ideagen PLC
16 October 2020
 

Ideagen PLC

("Ideagen," "the Company" or the "Group'')

Exercise of share options, issue of new shares and Total Voting Rights

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that it has allotted a total of 30,000 new ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") following the exercise of options by an employee.

Application has been made to the London Stock Exchange for the 30,000 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 22 October 2020.

After Admission, the total number of Ordinary Shares in issue will be 226,843,008 and the total number of voting rights will therefore be 226,843,008. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

Enquiries:

Ideagen plc

01629 699100

David Hornsby, Executive Chairman


Ben Dorks, Chief Executive Officer


Emma Hayes, Chief Financial Officer




finnCap Limited

020 7220 0500

Henrik Persson/James Thompson (Nomad)


Alice Lane (ECM)


Canaccord Genuity

020 7523 8000

Simon Bridges


Richard Andrews


About Ideagen plc

Ideagen is a UK-headquartered, global technology company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

The Group provides software and services to organisations operating within highly regulated industries such as aviation, banking and finance and life science, with its main operational premises spread throughout the UK, EU, US, Middle East and SE Asia.

With an excellent portfolio of software products including Q-Pulse, Coruson, Pentana Audit and PleaseReview, Ideagen helps its clients reduce costs, improve operational efficiency, strengthen compliance and oversight and anticipate and manage every detail of risk.

Currently, more than 5,000 organisations use Ideagen's products including seven of the top 10 UK accounting firms, all of the top aerospace and defence companies and 75% of the world's leading pharmaceutical firms.

Ideagen's diverse and varied customer base includes many well-known, global brands such as British Airways, Aggreko, BAE, Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank, Meggitt, Heineken, Johnson Matthey, Haeco Group and European Central Bank. As well as this, Ideagen counts 180 hospitals across the UK and US amongst its client base.

For further information please visit   www.ideagen.com .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCMFBBTMTIBBTM
Provided by: RNS
London AIM (United Kingdom)
IDEAGEN PLC
Ideagen Plc provides market-leading information management, safety, risk and compliance software solutions that allow organisations to achieve operational excellence, regulatory compliance and reduce risk....
Learn more about company

Related news

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date